Table 4.
Sedentary (n = 60) | Walkers (n = 21) | Bikers and runners (n = 24) | p value | |
---|---|---|---|---|
Severe | 78.3% (66.4–86.9) | 52.4% (32.4–71.7) | 62.5% (42.7–78.8) | 0.28 |
Age | 43.0 (31.0–53.0) | 44.0 (32.0–59.0) | 34.5 (24.5–55.3) | 0.40 |
HJHS total | 16.0 (7.5–34.0) | 15.5 (5.8–25.8) | 4.0 (1.0–29.0) | 0.07 |
HAL total | 74.5 (61.0–92.5) | 85.6 (76.7–93.9) | 90.3 (69.1–100) | 0.04 |
40m SPWT | 27.6 (25.1–31.0) | 26.5 (24.5–29.3) | 27.3 (25.8–28.9) | 0.52 |
VAS max | 4.5 (0.0–7.0) | 3.0 (2.0–7.0) | 1.0 (0.0–6.5) | 0.24 |
Median (IQR) and % (95% confidence interval).
Data were missing on 6.3% of clinical outcome values. Participants with missing data did not differ from participants with complete data based on clustering variables or clinical characteristics.
HAL, haemophilia activity list; HJHS, haemophilia joint health score; IQR, interquartile range; SPWT, self-paced walk test; VAS, visual analogue scale.